...
首页> 外文期刊>BioMed research international >Proteomics in Molecular Diagnosis: Typing of Amyloidosis
【24h】

Proteomics in Molecular Diagnosis: Typing of Amyloidosis

机译:蛋白质组学在分子诊断中的应用:淀粉样变性病的分型

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Amyloidosis is a group of disorders caused by deposition of misfolded proteins as aggregates in the extracellular tissues of the body, leading to impairment of organ function. Correct identification of the causal amyloid protein is absolutely crucial for clinical management in order to avoid misdiagnosis and inappropriate, potentially harmful treatment, to assess prognosis and to offer genetic counselling if relevant. Current diagnostic methods, including antibody-based amyloid typing, have limited ability to detect the full range of amyloid forming proteins. Recent investigations into proteomic identification of amyloid protein have shown promise. This paper will review the current state of the art in proteomic analysis of amyloidosis, discuss the suitability of techniques based on the properties of amyloidosis, and further suggest potential areas of development. Establishment of mass spectrometry aided amyloid typing procedures in the pathology laboratory will allow accurate amyloidosis diagnosis in a timely manner and greatly facilitate clinical management of the disease.
机译:淀粉样变性病是由错误折叠的蛋白质以聚集体形式沉积在人体细胞外组织中而导致器官功能受损的一组疾病。为了避免误诊和不适当的,潜在的有害治疗,评估预后并在必要时提供遗传咨询,正确鉴定病因淀粉样蛋白对于临床管理至关重要。当前的诊断方法,包括基于抗体的淀粉样蛋白分型,检测完整范围的淀粉样蛋白的能力有限。对淀粉样蛋白蛋白质组学鉴定的最新研究已显示出希望。本文将回顾淀粉样变性病蛋白质组学分析的最新技术,讨论基于淀粉样变性病特性的技术的适用性,并进一步提出潜在的发展领域。在病理实验室中建立质谱辅助的淀粉样蛋白分型程序将允许及时准确地诊断淀粉样变性病,并极大地促进了疾病的临床管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号